AAD 2026Abstract 74515
Dupilumab Improves Patient-Reported Symptom Control Among Adults With Moderate-to-Severe Atopic Dermatitis in Clinical Practice
6-Year Follow-up Results From the RELIEVE-AD Study
Wang Z, Yang M, Chao J, Martins B, Noonan K, Shumel B, Sierka D, Kimball A
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Atopic dermatitis & eczema
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.687 · Not in PubMed: details from Crossref